Biotech entity
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention NHS Scotland, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention UK National Screening Committee, all published on March 23, 2026.
Last mentioned: Mar 23, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention NHS Scotland, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention UK National Screening Committee, all published on March 23, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 11 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering UK National Screening Committee. Shared-story counts are live from our verified record — not editorial picks.
Data Review
Expected first quarterly report on screening uptake and identification rates in Scotland.
Scotland Launch
Scotland officially begins nationwide screening for all newborns.
UK NSC Recommendation
The UK National Screening Committee begins formal review of SMA for the newborn panel.
Zolgensma UK Approval
NHS England and Scotland reach deals to fund the world's most expensive gene therapy.
Scotland has officially become the first nation in the United Kingdom to implement routine newborn screening for Spinal Muscular Atrophy (SMA). This landmark public health initiative aims to identify the rare genetic condition within days of birth, enabling immediate access to life-saving gene therapies before irreversible muscle wasting occurs.
UK National Screening Committee is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
